Active Filter(s):
Details:
The joint research team focused on analyzing the effects of GCWB204 on main biomarkers from animal samples that underwent muscle reduction upon the use of the chemotherapeutic drug 5-Fluorouracil.
Lead Product(s): BST204
Therapeutic Area: Nutrition and Weight Loss Product Name: GCWB204
Highest Development Status: Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 25, 2021